Pseudomonadota (ID 319928) - BioProject

Format

Choose Destination

Links from Protein

Accession: PRJNA319928 ID: 319928

The comparative exploration of the genomes of methylotrophs that not using methane

Accession	PRJNA319928
Data Type	Genome sequencing and assembly
Scope	Multispecies
Organism	Pseudomonadota[Taxonomy ID: 1224] Bacteria; Pseudomonadota
Submission	Registration date: 19-Aug-2016 G.K.Skryabin IBPM PAS
Relevance	Environmental

Project Data:

Assembly level

Number of Assemblies

4
4

Assembly	WGS	BioSample	Strain	Taxonomy
GCA_001720135.1	MCRJ00000000	SAMN04912030	PK2	Methylobrevis pamukkalensis
GCA_001708935.1	MASI00000000	SAMN04915608	VKM B-2706	Methyloligella halotolerans
GCA_001720165.1	MCRI00000000	SAMN05178898	Bur 1	Methylophaga muralis
GCA_003007735.2	PXNQ00000000	SAMN04915612	VKM B-2159	Paracoccus methylarcula

Supplemental Content

2788500447: Methylophaga muralis Bur 1 [Integrated Microbial Genomes]
2788500447: Methylophaga muralis Bur 1
Integrated Microbial Genomes
2802429432: Methylarcula marina VKM B-2159 [Integrated Microbial Genomes]
2802429432: Methylarcula marina VKM B-2159
Integrated Microbial Genomes
2786546836: Methyloligella halotolerans VKM B-2706 [Integrated Microbial Genomes]
2786546836: Methyloligella halotolerans VKM B-2706
Integrated Microbial Genomes
SILVA LSU Database [SILVA]
SILVA LSU Database
SILVA
SILVA SSU Database [SILVA]
SILVA SSU Database
SILVA

Pseudomonadota
Pseudomonadota
Non-methane utilizing methylotrophs genome sequencing and assembly

BioProject
BioProject Links for Protein (Select 1057449829) (1)
BioProject
txid467011[Organism:noexp] (2)
PopSet
Study Protocol Summary - Safety, Effectiveness, and Cost-Effectiveness of New Or...
Study Protocol Summary - Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation
DISCUSSION - Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagu...
DISCUSSION - Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation

Your browsing activity is empty.

Activity recording is turned off.